Sunitinib (SU) in Combination with Trastuzumab (T) for the Treatment of Advanced Breast Cancer (ABC): Activity and Safety Results from a Phase II Study.

被引：0

作者：

Blay, J-Y

Lluch, A.

Gutierrez, M.

Martin, M.

Kozloff, M. F.

Prady, C.

Huang, X.

Verkh, L.

Chen, C.

Tassell, V

Kern, K.

Verma, S.

机构：

[1] Ctr Leon Berard, F-69373 Lyon, France

[2] Univ Lyon 1, F-69365 Lyon, France

[3] Hosp Clin Univ Valencia, Valencia, Spain

[4] Ctr Rene Huguenin, St Cloud, France

[5] Hosp Clin San Carlos, Madrid, Spain

[6] Ingalls Mem Hosp, Harvey, IL USA

[7] Hop Charles LeMoyne, Quebec City, PQ, Canada

[8] Pfizer Oncol, La Jolla, CA USA

[9] Pfizer Oncol, New York, NY USA

[10] Reg Canc Ctr, Toronto, ON, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：510S / 510S

页数：1